Pharmaceutical
Chemicals
Technology

Grifols

$18.01
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

$0.00 (0.00%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell Grifols and other stocks, options, ETFs, and crypto commission-free!

About

Grifols SA engages in the production of plasma derivatives. It operates through the following segments: Bioscience, Hospital, Diagnostic, Bio Supplies, and Others. Read More The Bioscience Segment includes all activities related with products deriving from human plasma for therapeutic use. The Hospital Segment comprises of all non-biological pharmaceutical products and medical supplies manufactured by group companies earmarked for hospital pharmacy. The Diagnostic Segment deals with the marketing of diagnostic testing equipment, reagents, and other equipment. The Bio Supplies segment consists of all transactions related to biological products for non-therapeutic use. The Others segment focuses on the rendering of manufacturing services to third party companies. The company was founded by José Antonio Grifols Roig on November 18, 1940 and is headquartered in Barcelona, Spain.

Employees
21,243
Headquarters
Barcelona, Catalonia
Founded
1940
Market Cap
4.64B
Price-Earnings Ratio
14.76
Dividend Yield
Average Volume
1.01M
High Today
$18.26
Low Today
$17.93
Open Price
$18.10
Volume
191.48K
52 Week High
$24.97
52 Week Low
$17.42

Collections

Pharmaceutical
Chemicals
Technology
Health
Medical
Advertising and Marketing
Manufacturing
Business Services

News

Yahoo FinanceMay 9

GRFS or ORINY: Which Is the Better Value Stock Right Now?

58
PR NewswireApr 30

Grifols Announces PharmacyKeeper Bidirectional Integration with Epic

BARCELONA, Spain, April 30, 2019 /PRNewswire/ -- Grifols (MCE: GRF, MCE: GRF.P,NASDAQ: GRFS), a leading global producer of plasma-derived medicines and provider of technologies and services for hospitals, clinics and compounding centers, announced today that its PharmacyKeeper Verification IV Workflow Management system now supports bidirectional integration with Epic.

26
Yahoo FinanceApr 29

Grifols Announces the Opening of its new Plasma Donor Center in Hinesville, Georgia

Investing $1.6 million into local community; set to employ over 40 people from the local area HINESVILLE, Ga., April 29, 2019 /PRNewswire/ -- Grifols is pleased to announce the opening of a new Biotest plasma donor center located at 108 West Hendry Street, Hinesville, Georgia. The 11,000 square foot state-of-the-art facility officially opened its doors for business on April 29, 2019. Ileana Carlisle, Biotest President, said "We look forward to being an active member of the Hinesville community. Th...

21

Earnings

$0.21
$0.25
$0.28
$0.32
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
$0.30 per share
Actual
Expected May 30, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.